Interestingly, the ctDNA methylome was recently explored in patients with intracranial tumors, demonstrating a high accuracy to distinguish among different intra- and extra-cranial tumors and between IDH-wild-type and IDH-mutant gliomas [22]. This evidence concerns the gene IDH2 and central nervous system cancer.